Asynchronous Telemedicine Platform as a Solution to Address Gaps in Human Papillomavirus (HPV) Screening in the United States [ID 946]

INTRODUCTION: The National Cancer Institute highlights socioeconomic disparities and geographic inaccessibility as major barriers to human papillomavirus (HPV) screening via pelvic examination, where the cervical sample is collected by a clinician. Telemedicine services offering alternative self-collection of vaginal samples may improve rates of HPV testing. METHODS: This retrospective study evaluated patients who self-enrolled in Nurx’s HPV screening services between 2020 and 2024. Patients had access to asynchronous evidence-based consultation, ongoing messaging, and at-home laboratory testing. Patients received counseling about HPV vaccination and care recommendations based on their laboratory results. The comprehensive intake and laboratory data were analyzed and summarized. RESULTS: Data from nearly 6,000 patients seeking HPV testing were analyzed. The average age was 37 years, and patients were geographically dispersed (notably, 47% in the South) and 22% lived in a medically underserved area. Of the 5,916 patients who requested the test, 3,381 completed the at-home vaginal self-swab kit (57%). The positive-screen rate was 15%. Among those who tested positive, 14% tested positive for HPV 16, 5% for HPV 18, and 90% for other high-risk HPV strains. These patients also received care for other sexual and reproductive health (SRH) services, including contraception (78%) and STI testing and treatment (31%). CONCLUSIONS/IMPLICATIONS: While warranting further efforts to improve completion rates, this study highlights the potential of asynchronous telemedicine to address gaps in HPV screening, particularly in underserved areas. As women delay essential cervical cancer preventative care, such platforms offer accessible, evidence-based solutions, emphasizing the importance of integrated SRH services.